image
Ocular Therapeutix, Inc. OCUL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.16
-7.66 %
$ 1.43 B
Market Cap
-8.4
P/E
BALANCE SHEET
252 M ASSETS
68.84%
Growth Rates
1Year 68.84%
3Years -1.26%
5Years 28.11%
7Years 18.92%
10Years 29.40%
161 M LIABILITIES
41.28%
Growth Rates
1Year 41.28%
3Years -4.67%
5Years 34.06%
7Years 32.10%
10Years 7.43%
91.1 M EQUITY
157.59%
Growth Rates
1Year 157.59%
3Years 6.19%
5Years 20.50%
7Years 8.34%
10Years 13.45%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Ocular Therapeutix, Inc.
image
Current Assets 232 M
Cash & Short-Term Investments 196 M
Receivables 26.2 M
Other Current Assets 10.2 M
Non-Current Assets 19.8 M
Long-Term Investments 0
PP&E 18.2 M
Other Non-Current Assets 1.61 M
Current Liabilities 34.9 M
Accounts Payable 4.39 M
Short-Term Debt 3.17 M
Other Current Liabilities 27.3 M
Non-Current Liabilities 126 M
Long-Term Debt 81.8 M
Other Non-Current Liabilities 44.2 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 195.8 102.3 164.2 228.1 54.4 54.1 41.5 32.9 30.8 37.4 17.5 23.9
Short Term Investments 0 0 0 0 0 0 0 35.2 74.3 37.4 0 0
Receivables 26.2 21.3 21.1 12.3 2.5 0.2 0.2 0.2 0.2 0.3 0.3 45 K
Inventory 2.3 2.0 1.2 1.2 1.0 0.2 0.1 0.1 0.1 0.1 0 0
Other Current Assets 7.9 4.0 9.5 8.0 4.5 3.4 1.5 2.8 3.2 0.9 0.2 0.7
Total Current Assets 232.2 129.6 191.3 246.2 60.2 56.2 43.3 69.9 107.0 76.2 18.0 24.3
PP&E 18.2 17.9 11.8 13.9 16.8 10.2 10.5 3.3 3.1 1.8 0.9 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 1.8 1.8 1.8 1.8 6.6 1.6 1.7 0.2 0 0 0
Other Long Term Assets 1.6 0 0 0 0 0 0 0 0 0.2 0.2 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 252.1 149.3 204.9 261.9 78.7 73.0 55.4 74.9 110.3 78.2 19.1 25.3
LIABILITIES
Accounts Payable 4.4 5.1 4.6 2.7 3.3 3.0 3.6 2.1 2.0 1.3 0.5 0.6
Short Term Debt 3.2 3.2 3.2 11.0 2.3 0 5.5 1.5 0 1.4 1.8 1.8
Other Current Liabilities 27.1 22.5 18.5 12.9 6.5 6.2 4.3 4.6 3.4 3.0 0.7 1.1
Total Current Liabilities 34.9 31.4 26.3 26.7 12.0 9.2 13.4 8.3 5.4 5.9 3.3 3.5
Long Term Debt 81.8 62.7 57.4 48.8 58.2 24.8 12.5 14.1 15.3 13.5 0.7 2.3
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 30.1 6.4 20.2 98.3 12.1 3.2 3.4 0.5 68 K 0.1 74.6 66.2
Total Liabilities 160.9 113.9 116.9 185.8 82.4 37.2 29.3 22.9 20.7 19.5 78.6 71.9
EQUITY
Common Stock 12 K 8 K 8 K 8 K 5 K 4 K 3 K 3 K 2 K 2 K 0 0
Retained Earnings (697.6) (616.8) (545.8) (539.3) (383.6) (297.2) (237.3) (173.9) (129.2) (89.4) (60.8) (47.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 5 K 68 K (2.2) (1.7) (1.3)
Total Equity 91.1 35.4 88.0 76.1 (3.6) 35.9 26.1 52.0 89.6 58.7 (59.5) (46.6)
Total Liabilities and Equity 252.1 149.3 204.9 261.9 78.7 73.0 55.4 74.9 110.3 78.2 19.1 25.3
SHARES OUTSTANDING
Common Shares Outstanding 79.8 76.9 76.4 60.8 45.3 38.1 28.8 24.8 23.2 10.7 3.0 3.0